Results 151 to 160 of about 3,016,518 (294)
Pillans, P. I., Opie, L .H.
openaire +3 more sources
Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy? [PDF]
Kylies D, Dreher L, Wenzel UO.
europepmc +1 more source
Apigenin Protects Hypertensive Intracerebral Hemorrhage by Regulating Trx1 Through Binding to PRDX2
ABSTRACT Intracerebral hemorrhage (ICH) remains the most severe stroke subtype with high mortality and disability rates. Although apigenin has shown cerebroprotective potential in preclinical studies, its mechanism of action, particularly in hypertensive ICH, remains poorly understood.
Hao‐chen Xu +6 more
wiley +1 more source
Pharmacoepidemiological surveillance of antihypertensive therapy
Vijay Chamle, Rishi Jain
doaj +1 more source
Factors associated with non-adherence to antihypertensive therapy and blood pressure control in Iraq. [PDF]
AbdElrahman M +12 more
europepmc +1 more source
Proposed mechanism by which notoginsenoside R2 (NGR2) attenuates renal interstitial fibrosis. In injured renal tubular epithelial cells, CASP2 downregulation and enhanced ubiquitin‐dependent degradation of ALDH3A1 disrupt mitochondria‐associated endoplasmic reticulum membranes (MAMs) and impair fatty acid oxidation (FAO), leading to lipid accumulation ...
Guanting Chen +10 more
wiley +1 more source
Knowledge, Attitudes, and Practices on Antihypertensive Therapy Among Older Patients with Hypertension: Structural Equation Modeling Analysis. [PDF]
Li S, Zhang H, Zhang J, Liu X.
europepmc +1 more source
THB activates cAMP‐Epac1 signaling to suppress autophagy‐dependent ferroptosis and alleviate DOX‐induced liver injury. ABSTRACT This study investigated the hepatoprotective mechanism of tetrahydroberberine (THB) against doxorubicin (DOX)‐induced liver injury.
Cheng Teng +9 more
wiley +1 more source
Serum Uric Acid Changes in Relation to Nighttime Blood Pressure Dipping Status in Patients on Antihypertensive Therapy. [PDF]
Zhang D, Huang QF, Li Y, Wang JG.
europepmc +1 more source
The present study establishes a paradigm shift in synthetic mRNA delivery through the convergence of three orthogonal chemistries—perfluoro‐acylation, bio‐orthogonal click cross‐linking, and disulfide reduction—within a single, modular polymer architecture. Abstract A fundamental constraint of conventional messenger RNA (mRNA) delivery systems is their
Yue Wang +8 more
wiley +1 more source

